comparemela.com
Home
Live Updates
Acelrx Chief Financial - Breaking News
Pages:
Latest Breaking News On - Acelrx chief financial - Page 1 : comparemela.com
AcelRx Pharmaceuticals, Inc (NASDAQ:ACRX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the AcelRx Second Quarter 2023 Financial Results Conference Call.
South korea
Pam palmer
Thomas yip
Raffi asadorian
Vince angotti
Ed arce
University of pittsburgh medical center
Department of defense
Exchange commission
Health photo
Us army
Acelrx pharmaceuticals inc
Department of defense or do
Alora pharmaceuticals
Acelrx pharmaceuticals
Call transcript august
AcelRx Pharmaceuticals, Inc (NASDAQ:ACRX) Q1 2023 Earnings Call Transcript
Operator: Hello, welcome to the AcelRx First Quarter 2023 Financial Results Conference Call.
San diego
United states
Ed arce
Brandon folkes
Vincent angotti
James molloy
Pam palmer
Raffi asadorian
Department of defense or do
Acelrx pharmaceuticals inc
Alora pharmaceuticals
Acelrx co
Alliance global partners
Exchange commission
Cantor fitzgerald
Acelrx pharmaceuticals
AcelRx Pharmaceuticals, Inc (NASDAQ:ACRX) Q4 2022 Earnings Call Transcript
Operator: Welcome to the AcelRx 2022 Full Year and Fourth Quarter Financial Results Conference Call.
United states
South korea
Pamela palmer
Raffi asadorian
Vincent angotti
Brandon folkes
Services university of the health sciences
Acelrx pharmaceuticals inc
Cantor fitzgerald
Defense health agency
Technology stocks to invest
Alora pharmaceuticals
Department of defense
Exchange commission
Coast guard
Health photo
AcelRx Pharmaceuticals, Inc (ACRX) Q3 2022 Results - Earnings Call Transcript
AcelRx Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ACRX) Q3 2022 Results Earnings Conference Call November 14, 2022, 04:30 PM ET Company Participants Raffi Asadorian - Chief Financial Officer.
United states
South korea
Ed arce
Pam palmer
Vince angotti
Pamela palmer
Vincent angotti
Raffi asadorian
Stuart goldstein
Lakhmir chawla
Thomas lee
Brandon folkes
Company participants
Us navy
Us air
Department of defense
vimarsana © 2020. All Rights Reserved.